Senate Health Committee Sends Nomination of Dr. Scott Gottlieb to be FDA Commissioner to Senate Floor

Posted on April 27, 2017

WASHINGTON, D.C., April 27 — The Senate’s health committee today favorably reported out the nomination of Dr. Scott Gottlieb to serve as the next Commissioner of the Food and Drug Administration (FDA). Dr. Gottlieb’s nomination is now ready for consideration by the full Senate.

“Dr. Gottlieb is the right person to lead the Food and Drug Administration in its vital mission and move the agency forward so that America’s patients benefit from the remarkable discoveries our nation’s researchers are working on,” said Chairman Lamar Alexander (R-Tenn.). “He has impressive qualifications from nearly every perspective; he has been a practicing physician, held three roles at FDA, and is a cancer survivor.”

He continued, “The Food and Drug Administration is always important, but there has never been a more important time for the FDA to take advantage of the significant funding given to medical research and new tools given to the agency through 21st Century Cures and turn that potential into results for American patients. Dr. Gottlieb understands the importance of the agency that I hope he will soon lead.” 

Dr. Gottlieb has held several positions at the FDA, serving as FDA Deputy Commissioner, as senior advisor to the FDA commissioner, and as the agency’s Director of Medical Policy Development.